SCHEMBL5197804

SCHEMBL5197804

CCCCCN(CC)C(N)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.52
CA1 P00915 4/20 0.52
CA9 Q16790 4/20 0.52
MGLL Q99685 1/20 0.48
CA2 P00918 2/20 0.43
MMP1 P03956 1/20 0.42
MMP2 P08253 1/20 0.42
MMP3 P08254 1/20 0.42
MMP8 P22894 1/20 0.42
ZDHHC20 Q5W0Z9 2/20 0.40
ZDHHC2 Q9UIJ5 1/20 0.40
LMNA P02545 1/20 0.39
HPGD P15428 2/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.38
DNM1 Q05193 1/20 0.37
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25271710 0.98 MGLL (0.52) CA12CA1CA9MGLLCA2
SCHEMBL7916908 0.98 MGLL (0.52) CA12CA1CA9MGLLCA2
SCHEMBL9350289 0.98 MGLL (0.52) CA12CA1CA9MGLLCA2
SCHEMBL25225230 0.98 MGLL (0.52) CA12CA1CA9MGLLCA2
SCHEMBL25225491 0.98 MGLL (0.52) CA12CA1CA9MGLLCA2
SCHEMBL25224505 0.98 MGLL (0.52) CA12CA1CA9MGLLCA2
SCHEMBL25227874 0.98 MGLL (0.52) CA12CA1CA9MGLLCA2
SCHEMBL293118 0.93 CA12 (0.59) CA12CA1CA9MGLLCA2
SCHEMBL293960 0.91 CA12 (0.48) CA12CA1CA9MGLLCA2
SCHEMBL25276975 0.88 CA12 (0.50) CA12CA1CA9MGLLCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4446310-A1 METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND Asahi Kasei Kabushiki Kaisha (JP) 2024-10-16 EP disclosed
WO-2023106377-A1 METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND 旭化成株式会社 2023-06-15 WO disclosed
CN-108884212-A Maleimide resin, hardening resin composition and its hardening thing 日本化药株式会社 2018-11-23 CN disclosed
CN-108350146-A The composition epoxy resin of alkyl is stretched containing long-chain 日产化学工业株式会社 2018-07-31 CN disclosed
CN-107663374-A Resin composition, semi-cured sheet and laminate 台燿科技股份有限公司 2018-02-06 CN disclosed
CN-105074400-B Ultraviolet sensor sheet, method for manufacturing same, and ultraviolet sensing method 富士胶片株式会社 2018-01-02 CN disclosed
CN-107091689-A Dispersion liquid 富士胶片株式会社 2017-08-25 CN disclosed
CN-102947262-B Compound having branched alkyl group or branched alkenyl group, optically isotropic liquid crystal medium, and optical device JNC CORP. (JP) 2016-04-13 CN disclosed
CN-105074400-A Ultraviolet sensor sheet, method for manufacturing same, and ultraviolet sensing method FUJIFILM CORP 2015-11-18 CN disclosed
CN-102395622-B Glass fiber composite semi-siloxane molded body and method for producing same JNC CORP 2015-02-04 CN disclosed
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US disclosed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275968-A1 Substituted Biphenyl Derivative COL2A1, COL1A1, FGFR3 CA12 1900/4885CA1 1466/4885CA9 1446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.